Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.
NCT: NCT07425548 · NOT_YET_RECRUITING
Brief Summary
Breast cancer, the most common cancer in women, is increasingly managed as a chronic disease thanks to therapeutic advances. However, treatments such as chemotherapy and hormonotherapy often induce premature menopause in younger women, leading to skin aging, atrophy, and distressing symptoms that negatively affect quality of life. These cutaneous effects are frequently overlooked despite their psychological and social impact. Hyaluronic acid injections, already well established in aesthetic and reconstructive medicine, may offer a safe, minimally invasive option to restore skin quality, improve self-esteem, and enhance overall well-being in breast cancer survivors. This study aims to assess their efficacy and safety in this specific population.
Frequently Asked Questions
What is Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.?
Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. is a clinical trial registered under NCT07425548. Current status: NOT_YET_RECRUITING.
What is the status of NCT07425548?
The current status of NCT07425548 (Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.) is: NOT_YET_RECRUITING.
When did Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. start?
Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. started on 2026-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.